Qualigen Therapeutics Provides Corporate Update for Third Quarter and To Date 2023
November 14, 2023 16:30 ET | Qualigen Therapeutics, Inc.
Initiated dosing of three patients in first cohort of Phase 1 clinical trial of QN-302 for treatment of advanced or metastatic solid tumorsPhase 1a patient recruitment ongoing; company anticipates...
FDCTech's Quarterly Release for the Third Quarter (FY23 Q3) Results
November 14, 2023 16:00 ET | FDCTech, Inc.
Compared to the previous period, the Company enhanced its technology business by 140% and 180% for the three and nine months ending September 30, 2023. The Company reported a net income of $638,084...
EG-Logo_Horizontal-Full Color.png
Enthusiast Gaming Reports Third Quarter 2023 Financial Results
November 13, 2023 16:15 ET | Enthusiast Gaming Inc.
LOS ANGELES, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Enthusiast Gaming Holdings Inc. (“Enthusiast Gaming” or the “Company”) (TSX: EGLX), a leading gaming media and entertainment company, today announced...
Pineapple Energy Reports Third Quarter 2023 Financial Results
November 09, 2023 16:15 ET | Pineapple Energy
Revenue up 211% from Q3 2022Gross profit up 401% from Q3 2022Operating Expenses up 125% from Q3 2022Net Loss from continuing operations decreased 8% from Q3 2022Pro forma adjusted EBITDA up 156% from...
GEG Q3 2023 EBITDA (English)
Galaxy Entertainment Group Selected Unaudited Q3 2023 Financial Data
Q3 2023 Group Adjusted EBITDA of $2.8 Billionup 576% Year-on-Year and up 12% Quarter-on-Quarter GICC, Galaxy Arena, Raffles at Galaxy Macau and Andaz Macau Continue to Ramp up Paid a...
Pieridae logo_Hunter.jpg
Pieridae Releases Q3 2023 Financial and Operating Results
November 08, 2023 18:51 ET | Pieridae Alberta Production Ltd.
CALGARY, Alberta, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Pieridae Energy Limited (“Pieridae” or the “Company”) (TSX: PEA) announces the release of its third quarter 2023 financial and operating results....
InterpaceBiosciences_New Logo.png
Interpace Biosciences Announces Record Third Quarter 2023 Financial and Business Results
November 08, 2023 15:29 ET | Interpace Biosciences, Inc.
 ●Q3 Revenue of $9.1 million; an 11% increase year-over-year ●Q3 Test volume up 11% year-over-year ●Q3 Reimbursement improvement up 11% year-over-year, driven by additional commercial contracts and...
NEURONES: Organic gr
NEURONES: Organic growth up 12.3% over the first nine months of the year
November 08, 2023 11:40 ET | NEURONES
PRESS INFORMATIONHeading: 3rd quarter 2023 revenues        Nanterre, November 8, 2023 (after trading) Organic growth up 12.3% over the first nine months of the year (not audited, in millions of...
NEURONES : + 12,3% d
NEURONES : + 12,3% de croissance organique en cumul à la fin du 3e trimestre 2023
November 08, 2023 11:40 ET | NEURONES
INFORMATION PRESSERubrique : C.A. 3e trimestre 2023        Nanterre, le 8 novembre 2023 (après Bourse) + 12,3% de croissance organique en cumul à la fin du 3e trimestre 2023 (non audités, en millions...
MRC Global Announces Third Quarter 2023 Results
November 07, 2023 16:15 ET | MRC Global
MRC Global, the leading PVF distributor reported third quarter 2023 earnings with 2% sequential topline growth and operating cash flow of $102 million.